These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22654656)

  • 1. Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
    Mostowy R; Kouyos RD; Hoof I; Hinkley T; Haddad M; Whitcomb JM; Petropoulos CJ; Keşmir C; Bonhoeffer S
    PLoS Comput Biol; 2012; 8(5):e1002525. PubMed ID: 22654656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.
    Boutwell CL; Carlson JM; Lin TH; Seese A; Power KA; Peng J; Tang Y; Brumme ZL; Heckerman D; Schneidewind A; Allen TM
    J Virol; 2013 Apr; 87(7):3952-65. PubMed ID: 23365420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission.
    Ngandu NK; Seoighe C; Scheffler K
    Virol J; 2009 Oct; 6():164. PubMed ID: 19818146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations.
    Batorsky R; Sergeev RA; Rouzine IM
    PLoS Comput Biol; 2014 Oct; 10(10):e1003878. PubMed ID: 25356981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase.
    Hinkley T; Martins J; Chappey C; Haddad M; Stawiski E; Whitcomb JM; Petropoulos CJ; Bonhoeffer S
    Nat Genet; 2011 May; 43(5):487-9. PubMed ID: 21441930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
    Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations.
    Maldonado JO; Mansky LM
    Viruses; 2018 Jul; 10(7):. PubMed ID: 30029500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level.
    Ahlenstiel G; Roomp K; Däumer M; Nattermann J; Vogel M; Rockstroh JK; Beerenwinkel N; Kaiser R; Nischalke HD; Sauerbruch T; Lengauer T; Spengler U;
    Clin Vaccine Immunol; 2007 Oct; 14(10):1266-73. PubMed ID: 17715334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein.
    Boutwell CL; Rowley CF; Essex M
    J Virol; 2009 Mar; 83(6):2460-8. PubMed ID: 19109381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
    Brumme ZL; Li C; Miura T; Sela J; Rosato PC; Brumme CJ; Markle TJ; Martin E; Block BL; Trocha A; Kadie CM; Allen TM; Pereyra F; Heckerman D; Walker BD; Brockman MA
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):100-8. PubMed ID: 21124229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.